Altered trajectories of neurodevelopment and behavior in mouse models of Rett syndrome.


Journal

Neurobiology of learning and memory
ISSN: 1095-9564
Titre abrégé: Neurobiol Learn Mem
Pays: United States
ID NLM: 9508166

Informations de publication

Date de publication:
11 2019
Historique:
received: 30 03 2018
revised: 17 10 2018
accepted: 16 11 2018
pubmed: 7 12 2018
medline: 31 7 2020
entrez: 4 12 2018
Statut: ppublish

Résumé

Rett Syndrome (RTT) is a genetic disorder that is caused by mutations in the x-linked gene coding for methyl-CpG-biding-protein 2 (MECP2) and that mainly affects females. Male and female transgenic mouse models of RTT have been studied extensively, and we have learned a great deal regarding RTT neuropathology and how MeCP2 deficiency may be influencing brain function and maturation. In this manuscript we review what is known concerning structural and coinciding functional and behavioral deficits in RTT and in mouse models of MeCP2 deficiency. We also introduce our own corroborating data regarding behavioral phenotype and morphological alterations in volume of the cortex and striatum and the density of neurons, aberrations in experience-dependent plasticity within the barrel cortex and the impact of MeCP2 loss on glial structure. We conclude that regional structural changes in genetic models of RTT show great similarity to the alterations in brain structure of patients with RTT. These region-specific modifications often coincide with phenotype onset and contribute to larger issues of circuit connectivity, progression, and severity. Although the alterations seen in mouse models of RTT appear to be primarily due to cell-autonomous effects, there are also non-cell autonomous mechanisms including those caused by MeCP2-deficient glia that negatively impact healthy neuronal function. Collectively, this body of work has provided a solid foundation on which to continue to build our understanding of the role of MeCP2 on neuronal and glial structure and function, its greater impact on neural development, and potential new therapeutic avenues.

Identifiants

pubmed: 30502397
pii: S1074-7427(18)30262-4
doi: 10.1016/j.nlm.2018.11.007
pmc: PMC8040058
mid: NIHMS1061315
pii:
doi:

Substances chimiques

Mecp2 protein, mouse 0
Methyl-CpG-Binding Protein 2 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

106962

Subventions

Organisme : NICHD NIH HHS
ID : U54 HD079123
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS100085
Pays : United States
Organisme : NINDS NIH HHS
ID : F32 NS010085
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS113140
Pays : United States
Organisme : NCRR NIH HHS
ID : S10 RR027445
Pays : United States

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Références

Hum Mol Genet. 2008 Jun 15;17(12):1707-17
pubmed: 18321865
Brain Res. 2013 Nov 6;1537:319-26
pubmed: 24060648
Nat Neurosci. 2013 May;16(5):543-51
pubmed: 23525041
Neurotherapeutics. 2015 Jul;12(3):631-40
pubmed: 25861995
Brain Dev. 2001 Dec;23 Suppl 1:S62-71
pubmed: 11738844
J Nucl Med. 1993 Oct;34(10):1717-21
pubmed: 8410289
Hum Mol Genet. 2014 Jan 15;23(2):303-18
pubmed: 24009314
Science. 2011 Sep 9;333(6048):1456-8
pubmed: 21778362
Nature. 1995 May 25;375(6529):325-8
pubmed: 7753197
Cold Spring Harb Perspect Biol. 2015 Aug 03;7(8):a021691
pubmed: 26238359
J Neurophysiol. 2016 Mar;115(3):1298-306
pubmed: 26683074
Ann Neurol. 2010 Dec;68(6):944-50
pubmed: 21154482
J Neurosci. 2011 Aug 31;31(35):12629-37
pubmed: 21880923
Elife. 2016 Jul 26;5:
pubmed: 27458802
Nature. 2015 Oct 15;526(7573):430-4
pubmed: 26469053
Nat Neurosci. 2005 Mar;8(3):380-8
pubmed: 15723060
Hum Mol Genet. 2016 Aug 1;25(15):3284-3302
pubmed: 27365498
J Neurosci Methods. 2014 Mar 15;224:48-57
pubmed: 24384067
Brain. 2006 Apr;129(Pt 4):887-98
pubmed: 16467389
Front Cell Neurosci. 2015 Apr 20;9:145
pubmed: 25941473
J Comp Neurol. 2009 May 20;514(3):240-58
pubmed: 19296534
Hum Mol Genet. 2008 Jun 15;17(12):1718-27
pubmed: 18321864
Hum Mol Genet. 2013 Jan 1;22(1):96-109
pubmed: 23026749
Curr Opin Neurobiol. 2014 Aug;27:8-15
pubmed: 24607651
PLoS One. 2012;7(3):e31896
pubmed: 22412847
Mol Autism. 2017 Mar 29;8:17
pubmed: 28367307
AJR Am J Roentgenol. 1992 Jul;159(1):177-83
pubmed: 1609693
Dev Med Child Neurol. 1996 Mar;38(3):212-25
pubmed: 8631518
Anat Rec (Hoboken). 2011 Oct;294(10):1624-34
pubmed: 21901842
Cell. 2013 Dec 19;155(7):1596-609
pubmed: 24360280
J Comp Neurol. 2008 May 1;508(1):184-95
pubmed: 18306326
Free Radic Biol Med. 2015 Jun;83:167-77
pubmed: 25708779
J Neuroimmunol. 2015 Feb 15;279:33-8
pubmed: 25669997
J Neurochem. 2009 Jan;108(2):361-71
pubmed: 19012748
Physiol Behav. 2010 Jun 1;100(3):255-63
pubmed: 20045424
Neuron. 2012 Dec 20;76(6):1078-90
pubmed: 23259945
Int J Biochem Cell Biol. 2016 Dec;81(Pt B):246-253
pubmed: 27425398
Trends Cogn Sci. 2012 Dec;16(12):584-92
pubmed: 23142417
Mediators Inflamm. 2014;2014:480980
pubmed: 24511209
Behav Brain Res. 2011 Jan 1;216(1):313-20
pubmed: 20713094
J Neurosci. 2015 Feb 11;35(6):2516-29
pubmed: 25673846
Front Cell Neurosci. 2014 Feb 24;8:56
pubmed: 24605086
Hum Mol Genet. 2016 May 15;25(10):1990-2004
pubmed: 26936821
Neuron. 2002 Jan 3;33(1):1-2
pubmed: 11779470
Can J Physiol Pharmacol. 2004 Aug-Sep;82(8-9):732-9
pubmed: 15523530
Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21966-71
pubmed: 20007372
Hum Mol Genet. 2002 Jan 15;11(2):115-24
pubmed: 11809720
Neuroscience. 1990;39(1):151-70
pubmed: 2089275
Nature. 2015 May 21;521(7552):E1-4
pubmed: 25993969
Sci Transl Med. 2017 Aug 16;9(403):
pubmed: 28814546
Nat Genet. 2001 Mar;27(3):322-6
pubmed: 11242117
Neuron. 2016 Aug 17;91(4):739-747
pubmed: 27499081
J Neuropathol Exp Neurol. 2005 Jun;64(6):537-44
pubmed: 15977646
Expert Opin Orphan Drugs. 2016 Oct 2;4(10):1043-1055
pubmed: 28163986
Ann Neurol. 1999 Apr;45(4):541-5
pubmed: 10211484
J Neurosci. 2015 Apr 15;35(15):6209-20
pubmed: 25878291
Neuron. 2007 Nov 8;56(3):422-37
pubmed: 17988628
J Neurosci. 2012 Jan 18;32(3):989-94
pubmed: 22262897
eNeuro. 2018 Jan 10;4(6):
pubmed: 29333487
PLoS One. 2012;7(4):e35354
pubmed: 22532851
Biol Psychiatry. 2010 Apr 1;67(7):657-65
pubmed: 20172507
Cereb Cortex. 2016 May;26(5):1938-1956
pubmed: 25662825
Neurobiol Dis. 2010 May;38(2):281-7
pubmed: 20138994
PLoS One. 2014 Dec 26;9(12):e115444
pubmed: 25541993
Nat Commun. 2014 Oct 09;5:5036
pubmed: 25297674
J Comp Neurol. 2017 Dec 15;525(18):3951-3961
pubmed: 28857161
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):2029-34
pubmed: 19208815
PLoS One. 2012;7(2):e31814
pubmed: 22457705
Curr Biol. 2006 Apr 4;16(7):710-6
pubmed: 16581518
Neuroscience. 2011 Apr 28;180:314-21
pubmed: 21296130
Neuroscience. 2006;139(4):1449-60
pubmed: 16549272
Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12560-5
pubmed: 16116096
Neurobiol Dis. 2017 Mar;99:1-11
pubmed: 27974239
Neurobiol Dis. 2012 Oct;48(1):102-14
pubmed: 22750529
Eur J Neurosci. 2008 Jun;27(12):3342-50
pubmed: 18557922
Annu Rev Neurosci. 2008;31:359-87
pubmed: 18558860
Orphanet J Rare Dis. 2014 Jun 19;9:87
pubmed: 24942262
Ann Neurol. 1993 Aug;34(2):227-34
pubmed: 8338347
AJNR Am J Neuroradiol. 2008 Mar;29(3):436-41
pubmed: 18065507
Hum Mol Genet. 2008 May 15;17(10):1386-96
pubmed: 18223199
Annu Rev Neurosci. 2015 Jul 8;38:433-47
pubmed: 25938726
Neurobiol Dis. 2006 Jan;21(1):217-27
pubmed: 16087343
Neurobiol Dis. 2011 Feb;41(2):385-97
pubmed: 20951208
Neurobiol Dis. 2009 Aug;35(2):219-33
pubmed: 19442733
Exp Neurol. 2018 Sep;307:74-81
pubmed: 29782864
Mol Autism. 2017 Jun 26;8:32
pubmed: 28670438
J Neuroinflammation. 2017 Dec 19;14(1):252
pubmed: 29258545
Hum Mol Genet. 2007 Oct 1;16(19):2315-25
pubmed: 17635839
J Neurosci. 2012 Oct 24;32(43):15106-11
pubmed: 23100431
Nature. 2012 Mar 18;484(7392):105-9
pubmed: 22425995
Free Radic Biol Med. 2015 Nov;88(Pt A):81-90
pubmed: 25960047
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):E1575-84
pubmed: 26929363
Neuroscience. 2007 May 25;146(3):907-21
pubmed: 17383101
Neuroscientist. 2007 Feb;13(1):49-61
pubmed: 17229975
Neuron. 2017 Jul 19;95(2):341-356.e6
pubmed: 28689984
Elife. 2018 Mar 23;7:
pubmed: 29570050
CNS Neurol Disord Drug Targets. 2010 Apr;9(2):174-91
pubmed: 20205642
Brain Dev. 1991;13(1):36-9
pubmed: 2063996
Neuron. 2007 Oct 4;56(1):58-65
pubmed: 17920015
J Neurosci. 2006 Jan 4;26(1):319-27
pubmed: 16399702
J Neurosci. 2010 Apr 14;30(15):5346-56
pubmed: 20392956
J Neurosci. 2009 Sep 9;29(36):11263-70
pubmed: 19741133
Front Neuroanat. 2014 Sep 10;8:97
pubmed: 25309341
J Appl Physiol (1985). 2012 Mar;112(5):704-10
pubmed: 22194327
Neuroscience. 2004;123(4):939-49
pubmed: 14751287
Brain Dev. 1987;9(5):517-22
pubmed: 3434730
Neurobiol Learn Mem. 2018 Mar;149:84-97
pubmed: 29438740
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):E7287-E7296
pubmed: 27803317
J Neurosci. 2012 Feb 1;32(5):1803-10
pubmed: 22302819
Oxid Med Cell Longev. 2015;2015:421624
pubmed: 26236424
Proc Natl Acad Sci U S A. 2015 Aug 25;112(34):E4782-91
pubmed: 26261347
Neurobiol Learn Mem. 2011 Nov;96(4):637-46
pubmed: 21624480
Neurobiol Dis. 2014 Aug;68:66-77
pubmed: 24769161
Neuropathol Appl Neurobiol. 2013 Feb;39(1):3-18
pubmed: 23252647
J Neurosci. 2013 Aug 21;33(34):13612-20
pubmed: 23966684
Int J Mol Sci. 2017 Dec 29;19(1):
pubmed: 29286317
Biol Psychiatry. 2016 May 1;79(9):755-764
pubmed: 26410354
J Neurosci. 2012 Oct 3;32(40):13860-72
pubmed: 23035095
Biol Psychiatry. 2016 May 1;79(9):746-754
pubmed: 26185009
Nat Neurosci. 2009 Mar;12(3):311-7
pubmed: 19234456
Brain Struct Funct. 2015 Jan;220(1):419-34
pubmed: 24218106
Neuropsychopharmacology. 2014 Nov;39(12):2846-56
pubmed: 24917201
Neuron. 2012 May 24;74(4):691-705
pubmed: 22632727
Adv Pharmacol. 1998;42:219-23
pubmed: 9327883
Brain Behav Immun. 2017 Feb;60:106-116
pubmed: 26883520
J Neurosci. 2012 Jul 18;32(29):10021-34
pubmed: 22815516
Immunity. 2015 Apr 21;42(4):679-91
pubmed: 25902482
J Neurosci. 2016 Nov 23;36(47):11946-11958
pubmed: 27881780
Neuropsychopharmacology. 2010 Jan;35(1):147-68
pubmed: 19794405
Genes Brain Behav. 2013 Oct;12(7):732-40
pubmed: 24283265

Auteurs

Elizabeth S Smith (ES)

Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Dani R Smith (DR)

Department of Psychological and Brain Sciences, Johns Hopkins University, Baltimore, MD 21218, USA.

Charlotte Eyring (C)

The Hugo W. Moser Research Institute at Kennedy Krieger, Inc., Baltimore, MD 21205, USA.

Maria Braileanu (M)

Undergraduate Program in Neuroscience, The Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore, MD 21218, USA.

Karen S Smith-Connor (KS)

The Hugo W. Moser Research Institute at Kennedy Krieger, Inc., Baltimore, MD 21205, USA.

Yew Ei Tan (Y)

Perdana University Graduate School of Medicine, Kuala Lumpur, Malaysia.

Amanda Y Fowler (AY)

Department of Biology, Morgan State University, Baltimore, MD 21251, USA.

Gloria E Hoffman (GE)

Department of Biology, Morgan State University, Baltimore, MD 21251, USA.

Michael V Johnston (MV)

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; The Hugo W. Moser Research Institute at Kennedy Krieger, Inc., Baltimore, MD 21205, USA.

Sujatha Kannan (S)

Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; The Hugo W. Moser Research Institute at Kennedy Krieger, Inc., Baltimore, MD 21205, USA.

Mary E Blue (ME)

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; The Hugo W. Moser Research Institute at Kennedy Krieger, Inc., Baltimore, MD 21205, USA. Electronic address: blue@kennedykrieger.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH